title: Persistent supravenous erythematous eruption-like changes from antibiotics.
authors.affiliation: Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
authors.affiliation: Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.
authors.forename: Risa
authors.initials: R
authors.lastname: Watanabe
authors.affiliation: Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Satoh
mesh_terms: D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000378:metabolism; D055499:Catheter-Related Infections / Q000188:drug therapy*; D003875:Drug Eruptions / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D004890:Erythema / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010878:Piperacillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D012867:Skin / Q000098:blood supply / Q000473:pathology; D014680:Veins / Q000378:metabolism
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D058846:Antibodies, Monoclonal, Murine-Derived; C500987:monoclonal antibody D2-40; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin